Episode 31: Autopsy
The Charles C. W. Cooke Podcast
00:00
The Future of Vaccines
I don't see how this vaccine goes on the schedule like the flu vaccine does, unless there's substantially better evidence produced by drug companies. That would require a real large-scale randomized study now,. Therefore, the marginal benefit of any additional vaccination vaccine doses is likely to be very, very low. The uptake for that bivalent booster that they recommended in the winter was abysmally low.
Transcript
Play full episode
